What does the evidence say about Vitamin D Depression Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Vitamin D Depression Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Vitamin D supplementation demonstrated a significant improvement in depressive symptoms compared to the placebo group (SMD: -0.98; 95% CI - 1.28 to -0.68; p I 2 = 79%; p Conclusion Our findings from this systematic review and meta-analysis indicated that vitamin D supplementation may be an effective adjunctive therapy for improving depressive symptoms. [Liu HH (2026); evidence level 1] - Higher daily doses, particularly around 5,000 IU, were associated with greater symptom improvement within the studied populations. [Liu HH (2026); evidence level 1] - Background Depression affects 5% of the global population, posing significant health and economic challenges. [Liu HH (2026); evidence level 1] - Objectives This study evaluates the efficacy of vitamin D supplementation in reducing depressive symptoms and explores its dose-response relationship. [Liu HH (2026); evidence level 1] - 3 4 5 6 7 8 8 9 10 10 11 Circadian misalignment has been unequivocally recognized as a risk factor for cardiometabolic diseases. [Vesković Milena (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.